The prognostic impact of plasma methylated HOXA9 in patients with advanced non-small cell lung cancer

Sara Witting Christensen Wen; Torben Hansen; Christa Haugaard Nyhus; Henrik Hager; Ole Hilberg; Rikke Fredslund Andersen; Anders Jakobsen

doi:10.1200/jco.2018.36.15_suppl.e24063

The prognostic impact of plasma methylated HOXA9 in patients with advanced non-small cell lung cancer

Sara Witting Christensen Wen, Torben Hansen, Christa Haugaard Nyhus, Henrik Hager, Ole Hilberg, Rikke Fredslund Andersen, Anders Jakobsen

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	e24063
Journal	Journal of Clinical Oncology
Volume	36
Issue number	15 Supplement
ISSN	0732-183X
DOIs	https://doi.org/10.1200/jco.2018.36.15_suppl.e24063
Publication status	Published - 2018

Documents & Links

10.1200/jco.2018.36.15_suppl.e24063

Cite this

@article{0005f9b197134d79bdd22e61104f5cd3,

title = "The prognostic impact of plasma methylated HOXA9 in patients with advanced non-small cell lung cancer",

author = "{Witting Christensen Wen}, Sara and Torben Hansen and {Haugaard Nyhus}, Christa and Henrik Hager and Ole Hilberg and {Fredslund Andersen}, Rikke and Anders Jakobsen",

year = "2018",

doi = "10.1200/jco.2018.36.15_suppl.e24063",

language = "English",

volume = "36",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15 Supplement",

}

TY - ABST

T1 - The prognostic impact of plasma methylated HOXA9 in patients with advanced non-small cell lung cancer

AU - Witting Christensen Wen, Sara

AU - Hansen, Torben

AU - Haugaard Nyhus, Christa

AU - Hager, Henrik

AU - Hilberg, Ole

AU - Fredslund Andersen, Rikke

AU - Jakobsen, Anders

PY - 2018

Y1 - 2018

U2 - 10.1200/jco.2018.36.15_suppl.e24063

DO - 10.1200/jco.2018.36.15_suppl.e24063

M3 - Conference abstract in journal

SN - 0732-183X

VL - 36

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15 Supplement

M1 - e24063

ER -